| Hapten-induced model of chronic inflammation and ulceration in the rat colon GP Morris, PL Beck, MS Herridge, WT Depew, MR Szewczuk, JL Wallace Gastroenterology 96 (2), 795-803, 1989 | 2474 | 1989 |
| Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates M Sambi, L Bagheri, MR Szewczuk Journal of oncology 2019, 2019 | 263 | 2019 |
| Impairment of host-versus-graft reaction in pregnant mice: II. Selective suppression of cytotoxic T-cell generation correlates with soluble suppressor activity and with … DA Clark, MR McDermott, MR Szewczuk Cellular Immunology 52 (1), 106-118, 1980 | 260 | 1980 |
| Neu1 desialylation of sialyl α-2, 3-linked β-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling SR Amith, P Jayanth, S Franchuk, T Finlay, V Seyrantepe, R Beyaert, ... Cellular signalling 22 (2), 314-324, 2010 | 229 | 2010 |
| Recent advances in “smart” delivery systems for extended drug release in cancer therapy RV Kalaydina, K Bajwa, B Qorri, A Decarlo, MR Szewczuk International journal of nanomedicine, 4727-4745, 2018 | 227 | 2018 |
| Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase SR Amith, P Jayanth, S Franchuk, S Siddiqui, V Seyrantepe, K Gee, ... Glycoconjugate journal 26, 1197-1212, 2009 | 161 | 2009 |
| Enhanced Suppressor Cell Activity as a Mechanism of Immunosuppression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin DA Clark, J Gauldie, MR Szewczuk, G Sweeney Proceedings of the Society for Experimental Biology and Medicine 168 (2 …, 1981 | 145 | 1981 |
| Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for Toll-like receptor activation and cellular signaling S Abdulkhalek, SR Amith, SL Franchuk, P Jayanth, M Guo, T Finlay, ... Journal of Biological Chemistry 286 (42), 36532-36549, 2011 | 111 | 2011 |
| Regulation of phagocytosis in macrophages by neuraminidase 1 V Seyrantepe, A Iannello, F Liang, E Kanshin, P Jayanth, S Samarani, ... Journal of biological chemistry 285 (1), 206-215, 2010 | 107 | 2010 |
| Loss of immune competence with age may be due to auto-anti-idiotypic antibody regulation MR Szewczuk, RJ Campbell Nature 286 (5769), 164-166, 1980 | 99 | 1980 |
| Non-nutritive sweeteners and their implications on the development of metabolic syndrome I Liauchonak, B Qorri, F Dawoud, Y Riat, MR Szewczuk Nutrients 11 (3), 644, 2019 | 98 | 2019 |
| A novel insulin receptor-signaling platform and its link to insulin resistance and type 2 diabetes F Alghamdi, M Guo, S Abdulkhalek, N Crawford, SR Amith, MR Szewczuk Cellular Signalling 26 (6), 1355-1368, 2014 | 96 | 2014 |
| A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer AM Gilmour, S Abdulkhalek, TSW Cheng, F Alghamdi, P Jayanth, ... Cellular signalling 25 (12), 2587-2603, 2013 | 87 | 2013 |
| Therapeutic potential of medicinal marijuana: an educational primer for health care professionals Y Mouhamed, A Vishnyakov, B Qorri, M Sambi, SMS Frank, C Nowierski, ... Drug, healthcare and patient safety, 45-66, 2018 | 81 | 2018 |
| Neu1 sialidase and matrix metalloproteinase-9 cross-talk is essential for neurotrophin activation of Trk receptors and cellular signaling P Jayanth, SR Amith, K Gee, MR Szewczuk Cellular signalling 22 (8), 1193-1205, 2010 | 80 | 2010 |
| Aging, idiotype repertoire shifts, and compartmentalization of the mucosal-associated lymphoid system AW Wade, MR Szewczuk Advances in immunology 36, 143-188, 1984 | 75 | 1984 |
| Neu1 sialidase and matrix metalloproteinase-9 cross-talk regulates nucleic acid-induced endosomal TOLL-like receptor-7 and-9 activation, cellular signaling and pro-inflammatory … S Abdulkhalek, MR Szewczuk Cellular Signalling 25 (11), 2093-2105, 2013 | 74 | 2013 |
| Lack of age-associated immune dysfunction in mucosal-associated lymph nodes. MR Szewczuk, RJ Campbell, LK Jung Journal of immunology (Baltimore, Md.: 1950) 126 (6), 2200-2204, 1981 | 74 | 1981 |
| Neuraminidase-1: A novel therapeutic target in multistage tumorigenesis F Haxho, RJ Neufeld, MR Szewczuk Oncotarget 7 (26), 40860, 2016 | 72 | 2016 |
| Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance LK O’Shea, S Abdulkhalek, S Allison, RJ Neufeld, MR Szewczuk OncoTargets and therapy, 117-134, 2014 | 70 | 2014 |
